Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the safety and perform preliminary clinical evaluation in patients with mild to moderate CDAD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT07087054 · Carcinoid Syndrome, Carcinoid, and more
NCT06237452 · Clostridium Difficile, Clostridium Difficile Infections, and more
NCT07196410 · Colitis, Diarrhea Caused by Antitumor Drugs
NCT07264998 · Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, and more
NCT04038619 · Colitis, Diarrhea, and more
Advanced Biologics
New Hope, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions